# Effectiveness of Vonoprazan vs Omeprazole as Empiric Therapy for Gastroesophageal Reflux Disease (GERD) Patients Without Alarm Features

> **NCT04028466** · PHASE4 · TERMINATED · sponsor: **St. Luke's Medical Center, Philippines** · enrollment: 82 (actual)

## Conditions studied

- GERD
- Gastro Esophageal Reflux

## Interventions

- **DRUG:** Vonoprazan
- **DRUG:** Omeprazole

## Key facts

- **NCT ID:** NCT04028466
- **Lead sponsor:** St. Luke's Medical Center, Philippines
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2019-05-26
- **Primary completion:** 2020-03-30
- **Final completion:** 2020-03-30
- **Target enrollment:** 82 (ACTUAL)
- **Why stopped:** Budget for the study was withdrawn and discontinued
- **Last updated:** 2023-11-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04028466

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04028466, "Effectiveness of Vonoprazan vs Omeprazole as Empiric Therapy for Gastroesophageal Reflux Disease (GERD) Patients Without Alarm Features". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04028466. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*